2-(3-cyano-4-hydroxyphenyl)-4-ethyl-1,3-thiazole-5-carboxylate CAS NO.161798-02-3

introduction of brant
hebei brant pharmaceutical co ltd is engaging in r&d&i and manufacture of pharmaceutical intermediates and api. we are specialized in chiral synthesis and resolution, total synthesis, enzyme catalytic reaction and process control technology.
brant pharmaceutical has a production base, a collaborating api production base, a r&d center and a university research lab.
brant has formed one set of modern enterprise management mechanism, innovation mechanism, performance appraisal and incentive mechanism, thus to achieve improvements to research system, production management system and market operation system. in the enterprise, all production and management and operation system are guided by gmp regulations. the company has been certificated with iso9001:2008 quality system certification, iso14001 environmental management system certificate and ohsas18000 occupational health and safety system.

philosophy and management
strategic position:
- focusing on customers’ demand in high priority
- taking the market as the orientation
- making a commercial manufacturing line under s&t expertise
- aiming to realize the cleaner production
market target:
- advancing our outreach to the pharmaceutical community
- having started working collaboratively with the leading global companies in specialty chemicals and api
commercial realization:
- the ideal combination of lab, pilot and manufacturing plant is promoting the conversion of more techniques and production of new compounds.
our values:
- focusing on our customers’ future first
- developing the talents of our people
- the courage and curiosity to question
- integrity and responsibility in our actions
- embracing entrepreneurial thinking
our mission:
- to advance the business of our customers and suppliers while progressing quality of life through the products
- to be at the forefront of developing technologies that bring value to our customers
- to be identified as a reliable partner of services and products to fine chemicals industries and apis
- to accelerate chemicals or drugs development programs to commercialization through the use of global resources
- to bridge customer needs with supplier capabilities; addressing all environmental, safety, and regulatory compliance requirements
technical strategy:
- to create the technology platforms that will make new horizons in r&d& production and new process technology that will lead to significant cost and sustainable gains
- to keep continuous improvement in the efficiency and effectiveness of r&d activities
- to reduce the discharge of waste to realize cleaner production
- to undertake collaborative product, process and technology development through open relationships
team members:
- ph d research specialists in chemical synthesis and enzyme catalysis
- master research specialists in various fields
- chemical engineers in design, process control and industrial scale-up
training system:
- to train employees to achieve their full potential
- to facilitate the transfer of the knowledge and know-how
- to perform the jobs in accordance with the company’s standards
management system:
- iso 9001:2008 (quality management system)
- iso 14001:2004 (environmental management system)
- ohsas 18001:2007 (occupational health and safety management activity and service)
2. manufacturing facilities
pilot facilities for chemicals
(1) reactors:
- 50 l to 500l glass, glass-lined and stainless steel reactors
(2) operating temperature
- from -80～250oc
(3) operating pressure
- atmospheric pressure to 0.6 mpa
manufacturing factories (workshops) for chemicals
(1) reactor size range:
- 1,000 l to 6,300l glass-lined and stainless steel reactors
(2) operating temperature
- from -35～140oc
(3) operating pressure
- atmospheric pressure to 0.6 mpa